Pfizer sets up Health Solutions subsidiary
This article was originally published in Clinica
Executive Summary
Pfizer has formed a new subsidiary to "create innovative products and services that improve the quality and efficiency of patient care". Through a series of alliances, Pfizer Health Solutions will focus on new ways to combine state-of-the-art disease diagnosis and treatment with advanced technology to improve healthcare providers' services. PHS will assist clinicians in making appropriate treatment decisions by providing relevant information at the point of care.
You may also be interested in...
Chinese Firms Up Their Game In Novel Flu Antiviral Development
Joincare Pharmaceutical and partner TaiGen Biotechnology tout preliminary Phase III results in uncomplicated acute influenza for TG-1000, a homegrown follower of Shionogi/Roche’s oral antiviral Xofluza. Novel antivirals for flu were hotly pursued by Chinese developers throughout 2023.
Quotable: Words Of Wisdom From Our Recent APAC Coverage
Scrip's APAC team selects notable quotes from recent interviews, conferences and other coverage to highlight the views of senior executives and officials on the major topics facing the biopharma sector in the region.
Generic Or Innovator? Sandoz Sues CMS Over Potential Change In Rebate Classification
Sandoz argued against paying higher rebates for two of its drugs via the Centers for Medicare and Medicaid Services’ Medicaid drug rebate program in a US court six years after the suggestion was first made.